1. Market Research
  2. > Healthcare Market Trends
  3. > General Medicine and Specialty Medicine

General & Specialty Medicine Market: Get Industry Insights

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
13 votes

More market segments:

Global General & Specialty Medicine

The general and specialty medecine industry is one level down from the section dedicated to the healthcare sector.

General medicine is concerned with treating chronic and acute diseases through preventive care, curative care and health education. In comparison, specialty medicine involves the treatment of specific medical conditions and illnesses. Major specialties within this branch of medicine include therapeutic, diagnostic, internal and surgical medicine.

Key Market Segments                                                       

The worldwide market for pain management therapeutics was worth almost $20 billion in 2010, according to GBI Research. The market recorded yearly growth in excess of 5% for the eight-year period ending 2010. Lyrica, an anticonvulsant, and Cymbalta, an anti-depressant, represent the leading products on the pain management market. Both are due to expire in 2013. The global pain management therapeutics industry is expected to record yearly growth of 3% between 2010 and 2017 to exceed $35 billion. Market leaders that will continue to fuel market growth include Pfizer’s Remoxy, UCB Group’s Vimpat, J&J’s Nucynta, Orexo’s Abstral and Teva’s Fentora.

Leading markets within the pain management therapeutics industry include post-operative pain, low-back pain and cancer pain relief markets. Post-operative pain relief represents the largest segment, reaching almost $6 billion in 2010 or 20% of the overall industry. The post-operative pain relief market was followed by the low-back pain market, which reached almost $5 billion in 2010, for more than 15% of the overall pain management therapeutics market. The cancer pain and neuropathic pain relief markets came third, accounting for a slightly lower percentage of the overall industry than the low-back pain market.

The global dermatology market is lead by demand for psoriasis treatment. There are less than 20 million sufferers worldwide, but it accounts for close to 20% of the overall dermatology market, reports Business Insights. The anti-acne market segment is fuelled by combination products, with leading products including Ziana by Medicis, Duac by GSK/Stiefel, and Sanofi’s BenzaClin. Dermatology sales generated $1.3 billion for leading company Leo Pharma in 2010, representing 20% year-on-year growth. The company is forecast to continue recording strong sales with the launch of its actinic keratosis treatment ingenol mebutate.

Sports medicine continues to benefit from technological developments. Arthroscopy, a minimally invasive technique has shortened recovery time for athletes. Most procedures are carried out to repair knee damage, reports Koncept Analytics. Sports-related injuries continue to rise due to changing lifestyles, and a growing interest in health and fitness. A higher demand for sports medicine also comes into play thanks to the world’s aging population and less-invasive arthroscopic surgery techniques. The greatest share of profit within sports medicine is derived from shoulder and knee treatments, with arthroscopic repairs marking the market segment with the fastest rate of growth. The US dominates the arthroscopic market, with Smith & Nephew remaining the leading company operating in the market. Other key companies include ArthroCare, Stryker, Conmed, DePuy Mitek and Arthrex.

Regional Market Share

The emerging nations of China, Russia, South Africa, Brazil and India hold immense potential for the general and specialty medical industry due to a significant number of patients whose needs are not currently being met. According to Global Data, there are over 120 million people aged 65 or older living in China. In India, more than a billion people, or 5% of the overall population, fall into this category. The country’s population is set to outpace that of China in around 20 years, which will make it the world’s most-densely populated nation. Healthcare demand is, therefore, set to continue rising at a high rate.

In Europe, facial aesthetics, medical laser devices and cosmetic surgery generated close to $660 million in 2010, according to research from iData Research. The market is expected to grow to $1.3 billion by 2017.

Read more »

Customer Support

Talk to Sam

+1 646 893 5945

19 Reports
Demographic, Supply, Demand
5 Statistics
Market Size, Demand, Finance
5 Reports
Demographic, Supply, Company Financials
4 Reports
Company Financials, Demographic, Market Structure
18 Reports
Company, Company Financials, Market Size
45 Statistics
Market Size, Demand, Company
65 Reports
Demographic, Company, Supply
230 Statistics
Market Size, Demand, Demographic
4 Reports
Company, Company Financials, Market Size
24 Statistics
Demand, Market Size, Finance
40 Reports
Demographic, Supply, Demand
470 Statistics
Demographic, Supply, Environment
3 Reports
Demand, Supply, Demographic
25 Statistics
Demographic, Environment, Demographic Indicators
12 Reports
Demographic, Company, Company Financials
82 Statistics
Demographic, Demographic Indicators, Environment
6 Reports
Demographic, Company Financials, Supply
37 Statistics
Demographic, Environment, Market Size
Search in General Medicine And Specialty Medicine Industry (About 800 reports)
Parent industry: Healthcare
Related industries: Diagnostics, Alternative Medicine, Managed Care, Health Services, Veterinary Healthcare, Medical Device, Medical Supply, Pathology, Health Insurance, E-Healthcare

About 800 reports

Purchase Reports From Reputable Market Research Publishers

Vascular Grafts - Cardiovascular Market Analysis and Forecast Model

Vascular Grafts - Cardiovascular Market Analysis and Forecast Model

  • $ 7500
  • Industry report
  • September 2017

Vascular Grafts - Cardiovascular Market Analysis and Forecast ModelSummaryVascular Grafts - Cardiovascular Market Analysis and Forecast Model is built to better visualize quantitative market trends of ...

Frontier Pharma: Transplantation Therapeutics - A Highl ... $ 6995 December 2017

Hematopoietic Stem Cell Transplantation - Market Insigh ... $ 6250 January 2018

Graft versus host disease (GVHD) - Market Insight, Epid ... $ 6250 January 2018

Canada Neurology Devices Market Outlook to 2025 - Hydro ... $ 5995 November 2018

EU5 Interventional Neuroradiology Market Outlook to 202 ... $ 5995 November 2018

South Korea Wound Care Management Market Outlook to 202 ... $ 5995 November 2017

Canada Wound Care Management Market Outlook to 2024 - A ... $ 5995 November 2017

China Wound Care Management Market Outlook to 2024 - Ad ... $ 5995 November 2017

India Wound Care Management Market Outlook to 2024 - Ad ... $ 5995 November 2017


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on